Announced Fri, 3 Jul · 18:59 IST
Bliss GVS Pharma appoints new CEO, Kamath steps down to MD role
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹504.00
prior close
₹505.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+1.4+0.7+0.4+0.6+0.9+4.5+4.2+5.2+2.2-9.4———
Up moveDown movePending
AI summary
Bliss GVS Pharma board on July 3, 2026 approved: (1) Mr. Santosh Parab (Chartered Accountant, 35+ years experience) as Additional Non-Executive Director; (2) Mr. Rahul Adakmol (ex-Dr. Reddy's, Bharat Serums, Reliance; IIM Bangalore; 22+ years) as new CEO effective July 15, 2026; (3) Mr. Narsimha Kamath stepping down as CEO on July 14, 2026 while continuing as Managing Director. Signals a planned leadership transition.
Likely market impact
Planned CEO transition with continuity as Kamath stays on as MD. New CEO brings 22 years of pharma industry leadership to drive next phase of growth.